Devana Solutions, LLC is committed to partnering with some of the world’s leading research sites to help shape the future of the clinical research industry. This week, Devana is pleased to announce the addition of Meridien Research and it’s affiliates to our growing subscriber-partner base. They’ve adopted Devana IGNITE for sites, a user-friendly software platform that simplifies the complex pipeline management process. IGNITE makes the management of business development, contact management, startup activities, study execution and performance metrics capture and analysis easier and faster.
By partnering with CROs and sponsors, Meridien Research study sites continue to be among the leaders in medical research and clinical trials in Florida. Meridien Research provides patients and families an opportunity to take part in clinical research trials for a wide variety of medical conditions. The professional teams at Meridien Research are experienced primarily in Phase Ib – Phase IV trials across a wide variety of therapeutic areas, including psychiatry, neurology, internal medicine, gastroenterology, OB/GYN, urology, cardiovascular risk-factors, endocrinology, and dermatology. Their studies across multiple locations in Central Florida, and its latest acquisition in Decatur, Georgia called NeuroStudies, help to further science and medicine.
It’s with great pride that we partner with another leading research site whose studies aid in the development of medical therapies that may offer better treatments, and even cures, for life-threatening and chronic diseases. We’re thrilled to welcome them aboard to help them drive better data, better decisions and better outcomes.